BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bisht S, Feldmann G. Animal models for modeling pancreatic cancer and novel drug discovery. Expert Opinion on Drug Discovery 2018;14:127-42. [DOI: 10.1080/17460441.2019.1566319] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Mallya K, Gautam SK, Aithal A, Batra SK, Jain M. Modeling pancreatic cancer in mice for experimental therapeutics. Biochim Biophys Acta Rev Cancer 2021;1876:188554. [PMID: 33945847 DOI: 10.1016/j.bbcan.2021.188554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Buschmann J, Heuberger DM, Kivrak Pfiffner F, Wolint P, Jang J, Jungraithmayr W, Giovanoli P, Calcagni M, Waschkies CF. Probing Vasoreactivity and Hypoxic Phenotype in Different Tumor Grafts Grown on the Chorioallantoic Membrane of the Chicken Embryo In Ovo Using MRI. Cancers 2022;14:3114. [DOI: 10.3390/cancers14133114] [Reference Citation Analysis]
3 Pineda-Farias JB, Saloman JL, Scheff NN. Animal Models of Cancer-Related Pain: Current Perspectives in Translation. Front Pharmacol 2020;11:610894. [PMID: 33381048 DOI: 10.3389/fphar.2020.610894] [Reference Citation Analysis]
4 Kalthoff H. How open is the therapeutic horizon for pancreatic cancer patients? Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00204-6. [PMID: 34789410 DOI: 10.1016/j.hbpd.2021.11.005] [Reference Citation Analysis]
5 Kokkinos J, Sharbeen G, Haghighi KS, Ignacio RMC, Kopecky C, Gonzales-Aloy E, Youkhana J, Timpson P, Pereira BA, Ritchie S, Pandzic E, Boyer C, Davis TP, Butler LM, Goldstein D, McCarroll JA, Phillips PA. Ex vivo culture of intact human patient derived pancreatic tumour tissue. Sci Rep 2021;11:1944. [PMID: 33479301 DOI: 10.1038/s41598-021-81299-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Meleady P, Abdul Rahman R, Henry M, Moriarty M, Clynes M. Proteomic analysis of pancreatic ductal adenocarcinoma. Expert Rev Proteomics 2020;17:453-67. [PMID: 32755290 DOI: 10.1080/14789450.2020.1803743] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Heinrich MA, Mostafa AMRH, Morton JP, Hawinkels LJAC, Prakash J. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Adv Drug Deliv Rev 2021;174:265-93. [PMID: 33895214 DOI: 10.1016/j.addr.2021.04.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
8 Feng Z, Meng H. Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology. Sci China Chem 2021;64:1946-57. [DOI: 10.1007/s11426-021-1126-x] [Reference Citation Analysis]
9 Huang S, Jiang C, Mughal MJ, Wang G, Xing F. An In Vivo Fluorescence Resonance Energy Transfer-Based Imaging Platform for Targeted Drug Discovery and Cancer Therapy. Front Bioeng Biotechnol 2022;10:839078. [PMID: 35237583 DOI: 10.3389/fbioe.2022.839078] [Reference Citation Analysis]
10 Ahmed AA, Angell R, Oxenford S, Worthington J, Williams N, Barton N, Fowler TG, O'Flynn DE, Sunose M, McConville M, Vo T, Wilson WD, Karim SA, Morton JP, Neidle S. Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models. ACS Med Chem Lett 2020;11:1634-44. [PMID: 32832034 DOI: 10.1021/acsmedchemlett.0c00317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]